About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ifng
interferon gamma
MGI:107656
204 phenotypes from 10 alleles in 30 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Ifngtm1(Thy1)Weav/?
involves: C57BL/6
no abnormal phenotype detected J:144542
Ifngtm1.1(KOMP)Vlcg/Ifng+
C57BL/6N-Ifngtm1.1(KOMP)Vlcg/Ucd
abnormal heart morphology J:211773
abnormal lung morphology J:211773
abnormal seminal vesicle morphology J:211773
decreased circulating total protein level J:211773
enlarged heart J:211773
increased erythrocyte cell number J:211773
increased hematocrit J:211773
Ifngtm1.1(KOMP)Vlcg/Ifngtm1.1(KOMP)Vlcg
C57BL/6N-Ifngtm1.1(KOMP)Vlcg/MbpMmucd
embryonic lethality prior to organogenesis J:211773
embryonic lethality prior to tooth bud stage J:211773
Ifngtm1.1(KOMP)Vlcg/Ifngtm1.1(KOMP)Vlcg
C57BL/6N-Ifngtm1.1(KOMP)Vlcg/Ucd
preweaning lethality, complete penetrance J:211773
Ifngtm1.1Hayg/Ifngtm1.1Hayg
Not Specified
abnormal B cell differentiation J:220784
abnormal bone marrow cell morphology/development J:220784
abnormal circulating cytokine level J:220784
abnormal cytokine level J:220784
abnormal erythropoiesis J:220784
abnormal hematopoietic stem cell morphology J:220784
abnormal lymph node morphology J:220784
abnormal proerythroblast morphology J:220784
abnormal T cell activation J:220784
anemia J:220784
decreased bone marrow cell number J:220784
decreased common myeloid progenitor cell number J:220784
decreased erythrocyte cell number J:220784
decreased erythroid progenitor cell number J:220784
decreased granulocyte monocyte progenitor cell number J:220784
decreased leukocyte cell number J:220784
decreased mature B cell number J:220784
decreased megakaryocyte cell number J:220784
decreased megakaryocyte-erythroid progenitor cell number J:220784
decreased myeloid cell number in bone marrow J:220784
decreased pre-B cell number J:220784
impaired hematopoiesis J:220784
increased erythroblast number J:220784
increased hematopoietic stem cell number J:220784
increased nucleated erythrocyte cell number J:220784
increased T cell number J:220784
pancytopenia J:220784
spleen atrophy J:220784
thrombocytopenia J:220784
thymus atrophy J:220784
Ifngtm1Lky/Ifngtm1Lky
involves: 129S4/SvJae * C57BL/6
normal immune system phenotype J:189794
Ifngtm1Ts/Ifngtm1Ts
B6.129S7-Ifngtm1Ts
abnormal B cell physiology J:112084
abnormal cytokine secretion J:18801, J:110826
abnormal immunoglobulin level J:18801
abnormal lymph node cell ratio J:112084
abnormal response to infection J:18801, J:110826
abnormal response to transplant J:42090
decreased IgG2a level J:18801
decreased IgG3 level J:18801
decreased tumor latency J:77491
increased CD8-positive, alpha-beta T cell number J:112048
increased IgE level J:18801
increased IgG1 level J:18801, J:112048
increased interleukin-2 secretion J:112048
increased interleukin-5 secretion J:112048
increased interleukin-10 secretion J:112048
increased lymphoma incidence J:77491
increased sarcoma incidence J:77491
increased susceptibility to Coronaviridae infection J:112048
increased susceptibility to Coronaviridae infection induced morbidity/mortality J:112048
increased susceptibility to parasitic infection J:18801
increased susceptibility to parasitic infection induced morbidity/mortality J:18801, J:110826
increased T cell derived lymphoma incidence J:77491
premature death J:77491
Ifngtm1Ts/Ifngtm1Ts
B6.129S7-Ifngtm1Ts/J
abnormal circulating cytokine level J:47459
abnormal cytokine secretion J:120556
abnormal dendritic cell antigen presentation J:134949
abnormal dendritic cell chemotaxis J:134949
abnormal dendritic cell physiology J:134949
abnormal humoral immune response J:45665
abnormal immune tolerance J:45665
abnormal immunoglobulin level J:45665
abnormal Langerhans cell physiology J:134949
abnormal macrophage chemotaxis J:136628
abnormal nitric oxide homeostasis J:122801
abnormal redox activity J:122801
abnormal response to injury J:136628
abnormal response to new environment J:54250
abnormal spleen morphology J:47459
abnormal spleen red pulp morphology J:47459
abnormal spleen white pulp morphology J:47459
abnormal type IV hypersensitivity reaction J:45665
abnormal urine homeostasis J:118730
albuminuria J:118730
decreased interferon-gamma secretion J:120556
decreased interleukin-10 secretion J:120556, J:134949
decreased length of allograft survival J:44346
decreased susceptibility to injury J:108148
decreased vertical activity J:54250
enlarged mesenteric lymph nodes J:50832
enlarged spleen J:47459
extramedullary hematopoiesis J:47459
glomerulonephritis J:118730
normal immune system phenotype J:114783
impaired skeletal muscle regeneration J:136628
increased circulating interleukin-6 level J:47459
increased fear-related response J:54250
increased granulocyte number J:47459
increased interleukin-4 secretion J:120556
increased interleukin-12 secretion J:134949
increased leukocyte cell number J:47459
increased monocyte cell number J:47459
increased NK T cell number J:122801
increased sensitivity to xenobiotic induced morbidity/mortality J:91927
increased susceptibility to bacterial infection J:47459
increased susceptibility to bacterial infection induced morbidity/mortality J:47459
increased susceptibility to parasitic infection J:50832
increased susceptibility to parasitic infection induced morbidity/mortality J:50832
increased susceptibility to type IV hypersensitivity reaction J:118730
pale spleen J:47459
skeletal muscle fibrosis J:136628
stomach inflammation J:120556
Ifngtm1Ts/Ifngtm1Ts
C.129S7(B6)-Ifngtm1Ts/J
abnormal adaptive immunity J:115144
abnormal circulating cytokine level J:47459
abnormal cytokine secretion J:115144
abnormal cytotoxic T cell physiology J:115144
abnormal inflammatory response J:115144
abnormal macrophage physiology J:115144
abnormal maternal decidual layer morphology J:56503
abnormal NK cell physiology J:115144
abnormal response to new environment J:54250
abnormal spleen morphology J:115144
abnormal spleen red pulp morphology J:47459
abnormal spleen white pulp morphology J:47459
abnormal tumor pathology J:115144
abnormal uterine NK cell morphology J:56503
abnormal uterine NK cell physiology J:56503
decreased litter size J:56503
decreased susceptibility to parasitic infection J:50832
decreased tumor latency J:115144
decreased vertical activity J:54250
enlarged spleen J:47459
extramedullary hematopoiesis J:47459
increased circulating interleukin-6 level J:47459
increased fear-related response J:54250
increased granulocyte number J:47459
increased leukocyte cell number J:47459
increased monocyte cell number J:47459
increased susceptibility to bacterial infection J:47459
increased susceptibility to bacterial infection induced morbidity/mortality J:47459
increased uterine NK cell number J:56503
pale spleen J:47459
Ifngtm1Ts/Ifngtm1Ts
C.129S7-Ifngtm1Ts
abnormal cytokine secretion J:110826
abnormal humoral immune response J:45665
abnormal immune tolerance J:45665
abnormal immunoglobulin level J:45665
abnormal response to infection J:110826
increased interleukin-5 secretion J:110826
increased lung adenocarcinoma incidence J:77491
increased susceptibility to bacterial infection induced morbidity/mortality J:83180
increased susceptibility to experimental autoimmune encephalomyelitis J:34161
increased susceptibility to parasitic infection J:110826
increased susceptibility to parasitic infection induced morbidity/mortality J:110826
increased tumor latency J:77491
normal neoplasm J:77491
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd
abnormal cytokine level J:112600
abnormal immunoglobulin level J:29170
abnormal response to infection J:29170, J:110721
corneal vascularization J:114973
decreased susceptibility to type IV hypersensitivity reaction J:29170
impaired natural killer cell mediated cytotoxicity J:73948
increased IgG1 level J:110721
increased interleukin-17 secretion J:132905
increased susceptibility to bacterial infection J:110856
increased susceptibility to bacterial infection induced morbidity/mortality J:110856
increased susceptibility to Herpesvirales infection J:29170
increased susceptibility to Herpesvirales infection induced morbidity/mortality J:29170
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss
decreased IgG2a level J:119207
decreased IgG level J:119207
decreased physiological sensitivity to xenobiotic J:119207
decreased susceptibility to autoimmune disorder J:119207
increased IgG1 level J:119207
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * BALB/c
abnormal susceptibility to infection J:39478
decreased airway responsiveness J:114213
decreased IgE level J:114213
decreased inflammatory response J:114213
normal immune system phenotype J:39881
increased airway responsiveness J:114213
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * C57BL/6
abnormal macrophage physiology J:66802
abnormal MHC II cell surface expression on macrophages J:66802
abnormal NK cell physiology J:66802, J:115033
abnormal skin physiology J:55740
abnormal type IV hypersensitivity reaction J:55740
alveolar process atrophy J:147935
decreased length of allograft survival J:44346
decreased susceptibility to parasitic infection J:189794
decreased susceptibility to parasitic infection induced morbidity/mortality J:189794
decreased tumor incidence J:138466
normal immune system phenotype J:119206
increased metastatic potential J:152785
increased splenocyte proliferation J:66802
increased susceptibility to bacterial infection J:66802
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * C57BL/6J
increased susceptibility to bacterial infection J:15723
increased susceptibility to bacterial infection induced morbidity/mortality J:15723
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp
decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased IgA level J:39600
decreased IgG2a level J:39600
decreased IgG2b level J:39600
decreased IgG3 level J:39600
decreased IgM level J:39600
decreased immunoglobulin level J:39600
decreased susceptibility to autoimmune disorder J:39600
Ifngtm1Ts/Ifngtm1Ts
involves: 129S7/SvEvBrd * NOD
normal immune system phenotype J:33427
Ifngtm1Ts/Ifngtm1Ts
NOD.129S7(B6)-Ifngtm1Ts/DvsJ
abnormal cytotoxic T cell physiology J:72818
abnormal diapedesis J:72818
abnormal pancreatic beta cell physiology J:72818
decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Ts/Ifngtm1Ts
NOD.129S7-Ifngtm1Ts
abnormal susceptibility to autoimmune disorder J:33427
decreased susceptibility to autoimmune diabetes J:95105
Ifngtm1Ts/Ifngtm1Ts
NOD.Cg-Ifngtm1Ts Prkdcscid
decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Yiw/Ifngtm1Yiw
B6.129X1-Ifngtm1Yiw
abnormal abdominal wall morphology J:50405
abnormal behavior J:50405
abnormal circulating interferon level J:91691
abnormal liver morphology J:50405
abnormal thoracic cavity morphology J:50405
ascites J:50405
focal hepatic necrosis J:91691
increased susceptibility to Coronaviridae infection J:50405, J:91691
increased susceptibility to Coronaviridae infection induced morbidity/mortality J:50405, J:91691
liver inflammation J:50405
peritoneal inflammation J:50405
Ifngtm1Yiw/Ifngtm1Yiw
C.129X1-Ifngtm1Yiw
abnormal circulating interferon level J:91691
diffuse hepatic necrosis J:91691
increased circulating alanine transaminase level J:91691
increased susceptibility to Coronaviridae infection J:91691
increased susceptibility to Coronaviridae infection induced morbidity/mortality J:91691
Ifngtm1Yiw/Ifngtm1Yiw
involves: 129X1/SvJ * C57BL/6
abnormal female reproductive system physiology J:59892
decreased apoptosis J:41632
decreased inflammatory response J:41632, J:88226
hepatic necrosis J:41632
Ifngtm3.1Lky/Ifngtm3.1Lky
B6.129S4-Ifngtm3.1Lky
no abnormal phenotype detected J:183078
Ifngtm3.1Lky/Ifngtm3.1Lky
C.129S4-Ifngtm3.1Lky
no abnormal phenotype detected J:183078
Tg(APCS-Ifng)5Imeg/0
involves: C57BL/6 * DBA/2
abnormal circulating enzyme level J:16979
abnormal cytokine level J:135124
abnormal heart echocardiography feature J:135124
abnormal heart morphology J:135124
abnormal liver morphology J:16979
abnormal myocardial fiber morphology J:135124
cardiac interstitial fibrosis J:135124
cardiac muscle atrophy J:135124
cardiac muscle degeneration J:135124
decreased cardiac muscle contractility J:135124
dilated cardiomyopathy J:135124
dilated heart left ventricle J:135124
increased circulating alanine transaminase level J:135124
increased circulating interleukin-12 level J:135124
liver fibrosis J:16979
liver inflammation J:16979, J:135124
liver vascular congestion J:135124
myocarditis J:135124
pancreas inflammation J:135124
premature death J:16979
Tg(GFAP-tTA)67Pop/0
Tg(tetO-Ifng)184Pop/0
B6.Cg-Tg(GFAP-tTA)67Pop Tg(tetO-Ifng)184Pop
abnormal cerebellum external granule cell layer morphology J:94092
abnormal cerebellum morphology J:94092
ataxia J:94092
increased medulloblastoma incidence J:94092
normal mortality/aging J:94092
neonatal lethality, incomplete penetrance J:94092
postnatal growth retardation J:94092
postnatal lethality, complete penetrance J:94092
tremors J:94092
Tg(GFAP-tTA)67Pop/0
Tg(tetO-Ifng)184Pop/0
involves: 129S/SvEv * C57BL/6 * DBA/2
increased medulloblastoma incidence J:94092
Tg(GFAP-tTA)78Pop/0
Tg(tetO-Ifng)184Pop/0
B6.Cg-Tg(GFAP-tTA)78Pop Tg(tetO-Ifng)184Pop
abnormal cerebellum development J:109838
abnormal cerebellum external granule cell layer morphology J:109838
abnormal interferon-gamma secretion J:109838
ataxia J:109838
CNS inflammation J:109838
decreased body size J:109838
enlarged cerebellum J:109838
Tg(GFAP-tTA)110Pop/0
Tg(tetO-Ifng)184Pop/0
involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * Swiss Webster
ataxia J:99655
normal mortality/aging J:99655
tremors J:99655
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
involves: C57BL/6 * CBA
abnormal lung volume J:100854
emphysema J:100854
increased apoptosis J:100854
increased lung compliance J:100854
increased lymphocyte cell number J:100854
increased macrophage cell number J:100854
increased neutrophil cell number J:100854

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/23/2021
MGI 6.16
The Jackson Laboratory